Finally, Vecchi and Goulart have shown that immunosuppressant cyclosporine A, which is also a weak antagonist of FPR1 (IC50 = 2–4 μM in calcium mobilisation assay27), retards tumour growth and invasiveness in a breast cancer in vivo model21. The gene discussed is FPR1; the disease is neoplasm.